MPP Strikes Long-Acting Injectable Cabotegravir Deal For HIV PrEP

Prospective Sub-Licensees Have Until 4 September To Submit Expressions Of Interest

 
• By David Wallace
  
MPP Medicines Patent Pool Logo Hand Syringe
The MPP has secured a license for long-acting injectable cabotegravir • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet